Well, the news is out. We’re on the verge of fully developing a coronavirus vaccine. The remedy comes by way of Pfizer, which is one of many companies that have been working on a formula to combat this deadly disease that has been putting certain portions of the world on lockdown for roughly eight months. This is good news to say the least, and yet it appears to have had a negative effect on bitcoin, which seemingly fell by more than $1,000 after the announcement was made.Bitcoin Falls After...
Read More »JNJ, MRNA Stocks Down Around 1.5%, J&J and Moderna to Produce Possible COVID-19 Vaccine
The U.S government has partnered Johnson & Johnson and Moderna to facilitate the production of the possible COVID-19 vaccine in large quantities.The government of the United States of America alongside Johnson & Johnson (NYSE: JNJ) and Moderna Inc (NASDAQ: MRNA) have partnered to produce in more substantial amounts possible vaccine for COVID-19 before the real vaccines hit the market. As per report, the U.S. government is also working to partner with not lesser than two other...
Read More »5 Companies Lead the Race in Producing the First COVID-19 Vaccine
Five pharmaceutical companies across the globe lead the race in producing the first approved COVID-19 vaccine. Wall Street is likewise on alert for banking on the first company to produce an efficient one.As the battle against the spread of coronavirus outbreak across the world intensifies, many companies are working to put themselves at the forefront in producing viable COVID-19 vaccine.Producing a vaccine for human testing and adoption to address the Coronavirus outbreak remains as crucial...
Read More »Johnson & Johnson Stock Up 7%, Human Testing of Coronavirus Vaccine to Begin by September
Johnson & Johnson after the announcement of the test of its coronavirus vaccine, JNJ stock has continued to surge, rising over 7%.Multinational pharmaceutical firm Johnson & Johnson (NYSE: JNJ) on Monday announced that human trial of its experimental vaccine for ravaging coronavirus will start September and would be ready for emergency use authorization early next year.After Johnson and Johnson made the announcement, the firm’s JNJ stock has continued to surge, rising over 7%.Johnson...
Read More »Abbott Laboratories (ABT) Stock Rose 8% in Pre-Market Trading and Is Up 6.83% Now
Abbott Laboratories (ABT) stock rises further following the company’s announcement about its system for identifying coronavirus. Today, during the pre-market hours, Abbott Laboratories shares were 8.77% up. Now they are 6.83% up.It is high time to see where do things stand in healthcare companies. One of them, Abbott Laboratories (NYSE: ABT), has recently got FDA approval on its coronavirus test m2000 RealTime System, which takes a 5-minute minimum to get the results. The test is portable and...
Read More »Germany’s Angela Merkel in Quarantine after Contact with Coronavirus-Infected Doctor
Merkel’s quarantine does not mean she will stop her official business, as the leader will continue working from home. She will also have regular COVID-19 tests in the coming days. Coronavirus gives no quarter to anyone, all of us can become at risk. Outstanding political leaders are no exception, and German Chancellor Angela Merkel has already checked it by her own experience. Currently, her ability to remain the public face of the country is under question, as after contact with...
Read More »At Least 20 Coronavirus Vaccines Are in Progress Globally, WHO Officials Confirm
As the search for COVID-19 vaccines intensifies, there are at least 20 coronavirus vaccines in the pipeline. However, Gilead Sciences (GILD) and Moderna (MRNA), the stocks of the leaders in the race, tumbled as the week came to the end.Coronavirus alias COVID-19 is the virus that has taken the humankind hostage for the past two months. It has led to most biotech companies to push beyond their limits in the search for a vaccine. As a result, the World Health Organization (WHO) officials...
Read More »Moderna (MRNA) Stock Down 10.48% after FDA Commissioner Comments on Vaccine Timeline
Moderna (MRNA) stock tanked by 10.48% on Thursday. The slide followed FDA Stephen Huhn’s statement that the COVID-19 vaccine is at least a year away.After a short upward, Moderna Inc (NASDAQ: MRNA) stock has plunged. Yesterday, it closed at $28.27, 10.48% down from the previous mark. Before, Moderna stock had a sweet period, albeit short, accompanied by the positive coronavirus news.Moderna (MRNA) Stock PriceOn March 16, the biotech company dosed the first patient in a study of its...
Read More »Waiting for Coronavirus Vaccine? Favipiravir or Avigan Can Cure Global Economy
Avigan, also known as Favipiravir, is a Japanese flu drug developed by the healthcare arm of Fujifilm. 340 patients taking the drug found it reduces recovery time and improves their lung condition. Enthralled by COVID-19, the world is waiting for a hero who will find the coronavirus vaccine. And one of the most widely-discussed variants to treat coronavirus today is Favipiravir (or Avigan). Worldwide famous biotech companies such as Gilead Sciences Inc (NASDAQ: GILD), Inovio Pharmaceuticals...
Read More »Inovio (INO) Stock Plunges 28% in Pre-Market Results Today Following Disappointing Q4 Report
Inovio stock has been swung significantly in the last 24 hours after rising on news of a new grant and plunging on news of its poor Q4 report.The continuous spread of the coronavirus COVID-19 strain has directly placed a large spotlight on biotech companies and their stock. Because most of them are scrambling to find some treatment or vaccine for the virus, they have seen sharp spikes in value like never before experienced. For Inovio Pharmaceuticals (NASDAQ: INO) stock, several market...
Read More »